Differentiation of pulmonary cytokines and purinergic molecules with potential prognostic value and immunomodulatory properties in non-small cell lung cancer patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00005415

Enrollment

Registered

2013-11-08

Start date

2013-11-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C34

Interventions

Group 1: Bronchoalveolar lavages are taken from patients with either proven or suspected non-small-cell lung cancer and directly analyzed for ATP concentrations. Cells and bronchoalveolar lavage fluid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with suspected or proven non-small-cell lung cancer

Exclusion criteria

Exclusion criteria: Other malignant disease, other lung disease like asthma, sarcoidosis, fibrosis (not COPD), acute systemic or pulmonary infection, patients undergoing chemotherapie, immunosuppressive therapy

Design outcomes

Primary

Measure	Time frame
Measurement of ATP directly after sample acquisition. Measurement of cytokines via ELISA and RNA via qPCR after completion of patient recruitment.	—

Countries

Germany

Contacts

Public ContactSeverin Schmid

Universitätsklinikum FreiburgDepartment ChirurgieKlinik für Thoraxchirurgie

Severin.Schmid@uniklinik-freiburg.de0761 270 24010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026